litlas
ログインアカウント作成

Tjalling Bosse

2006–2026 年に発表

112
論文数
20,679
被引用数
69
h 指数
109
i10 指数

被引用数

Tjalling Bosse の年別被引用数1994 年: 被引用 2 件2006 年: 被引用 1 件2007 年: 被引用 2 件2008 年: 被引用 3 件2009 年: 被引用 1 件2010 年: 被引用 4 件2011 年: 被引用 6 件2012 年: 被引用 6 件2013 年: 被引用 9 件2014 年: 被引用 16 件2015 年: 被引用 47 件2016 年: 被引用 110 件2017 年: 被引用 93 件2018 年: 被引用 148 件2019 年: 被引用 599 件2020 年: 被引用 919 件2021 年: 被引用 1,150 件2022 年: 被引用 1,113 件2023 年: 被引用 1,038 件2024 年: 被引用 1,626 件2025 年: 被引用 666 件2026 年: 被引用 17 件1995〜2005 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,238 件、この内訳の 17.7%中国: 引用元論文 968 件、この内訳の 13.9%イタリア: 引用元論文 619 件、この内訳の 8.9%イギリス: 引用元論文 431 件、この内訳の 6.2%オランダ: 引用元論文 409 件、この内訳の 5.9%カナダ: 引用元論文 297 件、この内訳の 4.3%スペイン: 引用元論文 283 件、この内訳の 4.1%ドイツ: 引用元論文 274 件、この内訳の 3.9%フランス: 引用元論文 267 件、この内訳の 3.8%日本: 引用元論文 192 件、この内訳の 2.7%オーストラリア: 引用元論文 149 件、この内訳の 2.1%スイス: 引用元論文 148 件、この内訳の 2.1%
0%17.7%その他 24.4%

機関

分野

  • Medicine74.7%
  • Biochemistry, Genetics and Molecular Biology15.8%
  • Immunology and Microbiology3.4%
  • Engineering3.1%
  • Computer Science1.5%
  • Neuroscience0.3%
  • その他1.2%

トピック

  • Endometrial and Cervical Cancer Treatments11.9%
  • Ovarian cancer diagnosis and treatment5.5%
  • Cancer Immunotherapy and Biomarkers5.4%
  • Genetic factors in colorectal cancer4.9%
  • Cancer Genomics and Diagnostics4.1%
  • Cancer Cells and Metastasis3.2%
  • その他65%

共著者

全論文

検索で開く
  1. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma

    著者: Nicole Concin, Xavier Matías‐Guiu, Ignace Vergote, David Cibula, Mansoor Raza Mirza, Simone Marnitz, Jonathan A. Ledermann, Tjalling Bosse, Cyrus Chargari, Anna Fagotti, Christina Fotopoulou, Antonio González-Martı́n, Sigurd Lax, Domenica Lorusso, Christian Marth, Philippe Morice, Remi A. Nout, D. O’Donnell, Denis Querleu, Maria Rosaria Raspollini, Jalid Sehouli, Alina Sturdza, Alexandra Taylor, Anneke M. Westermann, Pauline Wimberger, Nicoletta Colombo, François Planchamp, Carien L. Creutzberg - Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2020 被引用: 1,933

  2. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity

    著者: Oded Kopper, Chris J. de Witte, Kadi Lõhmussaar, Jose Espejo Valle-Inclán, Nizar Hami, Lennart Kester, Anjali Vanita Balgobind, Jeroen Korving, Natalie Proost, Harry Begthel, Lise M. van Wijk, Sonia Aristín Revilla, Rebecca Theeuwsen, Marieke van de Ven, Markus J. van Roosmalen, Bas Ponsioen, Victor W. Ho, Benjamin G. Neel, Tjalling Bosse, Katja N. Gaarenstroom, Harry Vrieling, Maaike P.G. Vreeswijk, P. J. van Diest, Petronella O. Witteveen, Trudy Jonges, Johannes L. Bos, Alexander van Oudenaarden, Ronald P. Zweemer, Hugo J.G. Snippert, Wigard P. Kloosterman, Hans Clevers - Nature Medicine 2019 被引用: 839

  3. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach

    著者: Claudio Luchini, Frédéric Bibeau, M. Ligtenberg, Naveena Singh, Alessia Nottegar, Tjalling Bosse, Robert E. Miller, Nadeem Riaz, J-Y Douillard, Fabrice André, Aldo Scarpa - Annals of Oncology 2019 被引用: 1,054

  4. Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    著者: Ana Oaknin, Tjalling Bosse, Carien L. Creutzberg, Gonzalo Giornelli, Philipp Harter, Florence Joly, Domenica Lorusso, Christian Marth, Vicky Makker, Mansoor Raza Mirza, Jonathan A. Ledermann, Nicoletta Colombo - Annals of Oncology 2022 被引用: 638

  5. Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

    著者: Alicia León‐Castillo, Stephanie M. de Boer, Melanie Powell, Linda Mileshkin, Helen Mackay, Alexandra Léary, Hans W. Nijman, Naveena Singh, Pamela M. Pollock, Paul Bessette, Anthony Fyles, Christine Haie-Méder, Vincent T.H.B.M. Smit, Richard J. Edmondson, Hein Putter, Henry C Kitchener, Emma J. Crosbie, Marco de Bruyn, Remi A. Nout, Nanda Horeweg, Carien L. Creutzberg, Tjalling Bosse - Journal of Clinical Oncology 2020 被引用: 837

  6. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts

    著者: Ellen Stelloo, Remi A. Nout, Elisabeth M. Osse, Ina J. Jürgenliemk-Schulz, Jan J. Jobsen, Ludy Lutgens, Elzbieta M. van der Steen‐Banasik, Hans W. Nijman, Hein Putter, Tjalling Bosse, Carien L. Creutzberg, Vincent T.H.B.M. Smit - Clinical Cancer Research 2016 被引用: 858

  7. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

    著者: Nicoletta Colombo, Carien L. Creutzberg, Frédéric Amant, Tjalling Bosse, Antonio González-Martı́n, Jonathan A. Ledermann, Christian Marth, Remi A. Nout, Denis Querleu, Mansoor Raza Mirza, Cristiana Sessa, Miguel Abal, Özden Altundağ, Frédéric Amant, Antoni Van Leeuwenhoek, Susana Banerjee, Tjalling Bosse, Antonio Casado, L Chiva de Agustín, David Cibula, Nicoletta Colombo, Carien L. Creutzberg, José María Del Campo, Günter Emons, Frédéric Goffin, Antonio González-Martı́n, Stefano Greggi, Christine Haie-Méder, Dionyssios Katsaros, Vesna Kesić, Christian Kurzeder, Sigurd Lax, Fabrice Lécuru, Jonathan A. Ledermann, Tally Levy, Domenica Lorusso, Johanna Mäenpää, Christian Marth, Xavier Matías‐Guiu, Philippe Morice, Hans W. Nijman, Remi A. Nout, Melanie Powell, Denis Querleu, Mansoor Raza Mirza, Nicholas Reed, Alexandros Rodolakis, Helga B. Salvesen, Jalid Sehouli, Cristiana Sessa, Alexandra Taylor, Anneke M. Westermann, Alain G. Zeimet - Annals of Oncology 2015 被引用: 1,380

  8. Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas

    著者: Alicia León‐Castillo, Ester Gilvazquez, Remi A. Nout, Vincent T.H.B.M. Smit, Jessica N. McAlpine, Melissa K. McConechy, Stefan Kommoss, Sara Y. Brucker, Joseph W. Carlson, E. Epstein, Tilman T. Rau, Robert A. Soslow, Raji Ganesan, Xavier Matías‐Guiu, Esther Oliva, Beth Harrison, David N. Church, C. Blake Gilks, Tjalling Bosse - The Journal of Pathology 2019 被引用: 402

  9. Interpretation of somatic POLE mutations in endometrial carcinoma

    著者: Alicia León‐Castillo, Heidi Britton, Melissa K. McConechy, Jessica N. McAlpine, Remi A. Nout, Stefan Kommoss, Sara Y. Brucker, Joseph W. Carlson, E. Epstein, Tilman T. Rau, Tjalling Bosse, David N. Church, C. Blake Gilks - The Journal of Pathology 2019 被引用: 392

  10. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

    著者: Lisa Vermij, Jan J. Jobsen, Alicia León‐Castillo, Mariël Brinkhuis, Suzan Roothaan, Melanie Powell, Stephanie M. de Boer, Pearly Khaw, Linda Mileshkin, Anthony Fyles, Alexandra Léary, Catherine Genestie, Ina M. Jürgenliemk‐Schulz, Emma J. Crosbie, Helen Mackay, Hans W. Nijman, Remi A. Nout, Vincent T.H.B.M. Smit, Carien L. Creutzberg, Nanda Horeweg, Tjalling Bosse, Stephanie M. de Boer - British Journal of Cancer 2023 被引用: 162

  11. A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer

    著者: Hagma H. Workel, Joyce M. Lubbers, Roland Arnold, Thalina M. Prins, Pieter van der Vlies, Kim de Lange, Tjalling Bosse, Inge C. van Gool, Florine A. Eggink, Maartje C.A. Wouters, Fenne L. Komdeur, Elisabeth C. van der Slikke, Carien L. Creutzberg, Arjan Kol, Annechien Plat, Mark A. Glaire, David N. Church, Hans W. Nijman, Marco de Bruyn - Cancer Immunology Research 2019 被引用: 262

  12. p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies

    著者: Naveena Singh, Anna Piskorz, Tjalling Bosse, Mercedes Jimenez‐Liñan, Brian Rous, James D. Brenton, C. Blake Gilks, Martin Köbel - The Journal of Pathology 2019 被引用: 298

  13. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts

    著者: Sarah Fremond, Sonali Andani, Jurriaan Barkey Wolf, Jouke Dijkstra, Sinéad Melsbach, Jan J. Jobsen, Mariël Brinkhuis, Suzan Roothaan, Ina J. Jürgenliemk-Schulz, Ludy Lutgens, Remi A. Nout, Elzbieta M. van der Steen‐Banasik, Stephanie M. de Boer, Melanie Powell, Naveena Singh, Linda Mileshkin, Helen Mackay, Alexandra Léary, Hans W. Nijman, Vincent T.H.B.M. Smit, Carien L. Creutzberg, Nanda Horeweg, Viktor H. Koelzer, Tjalling Bosse - The Lancet Digital Health 2022 被引用: 124

  14. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients

    著者: Nanda Horeweg, Hagma H. Workel, Dominik Loiero, David N. Church, Lisa Vermij, Alicia León‐Castillo, Ricki T. Krog, Stephanie M. de Boer, Remi A. Nout, Melanie Powell, Linda Mileshkin, Helen Mackay, Alexandra Léary, Naveena Singh, Ina M. Jürgenliemk‐Schulz, Vincent T.H.B.M. Smit, Carien L. Creutzberg, Viktor H. Koelzer, Hans W. Nijman, Tjalling Bosse, Marco de Bruyn, Nanda Horeweg, David N. Church, Stephanie M. de Boer, Remi A. Nout, Melanie Powell, Linda Mileshkin, Helen Mackay, Alexandra Léary, Naveena Singh, Carien L. Creutzberg, Hans W. Nijman, Tjalling Bosse, Marco de Bruyn - Nature Communications 2022 被引用: 144

  15. Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

    著者: Tjalling Bosse, Remi A. Nout, Jessica N. McAlpine, Melissa K. McConechy, Heidi Britton, Yaser Hussein, Carlene Gonzalez, Raji Ganesan, Jane C. Steele, Beth Harrison, Esther Oliva, August Vidal, Xavier Matías‐Guiu, Nadeem R. Abu‐Rustum, Douglas A. Levine, C. Blake Gilks, Robert A. Soslow - The American Journal of Surgical Pathology 2018 被引用: 342

  16. p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial

    著者: Lisa Vermij, Alicia León‐Castillo, Naveena Singh, Melanie Powell, Richard J. Edmondson, Catherine Genestie, Pearly Khaw, Jan Pyman, C. Meg McLachlin, Prafull Ghatage, Stephanie M. de Boer, Hans W. Nijman, Vincent T.H.B.M. Smit, Emma J. Crosbie, Alexandra Léary, Carien L. Creutzberg, Nanda Horeweg, Tjalling Bosse, Nanda Horeweg, Stephanie M. de Boer, Carien L. Creutzberg, Tjalling Bosse, Vincent T.H.B.M. Smit, Judith R. Kroep, Remi A. Nout, Hans W. Nijman, Marco de Bruyn, Melanie Powell, Naveena Singh, H. Kitchener, Emma J. Crosbie, Richard J. Edmondson, David N. Church, Alexandra Léary, Linda Mileshkin, Pamela M. Pollock, Helen Mackay - Modern Pathology 2022 被引用: 161

  17. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials

    著者: Tjalling Bosse, Elke E.M. Peters, Carien L. Creutzberg, Ina M. Jürgenliemk‐Schulz, Jan J. Jobsen, Jan Willem Mens, Ludy Lutgens, Elzbieta M. van der Steen‐Banasik, Vincent T.H.B.M. Smit, Remi A. Nout - European Journal of Cancer 2015 被引用: 430

  18. PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

    著者: Anne Sophie V M van den Heerik, Nanda Horeweg, Remi A. Nout, Ludy Lutgens, Elzbieta M. van der Steen‐Banasik, Henrike Westerveld, Hetty A. van den Berg, Annerie Slot, Friederike Koppe, Stefan Kommoss, Jan Willem Mens, Marlies E. Nowee, S. Bijmolt, David Cibula, Tanja C. Stam, Ina M. Jürgenliemk‐Schulz, An Snyers, Moritz Hamann, A.G. Zwanenburg, V. Coen, Katrien Vandecasteele, Charles Gillham, Cyrus Chargari, Karen Verhoeven-Adema, Hein Putter, Wilbert B. van den Hout, Bastiaan G. Wortman, Hans W. Nijman, Tjalling Bosse, Carien L. Creutzberg - International Journal of Gynecological Cancer 2020 被引用: 248

  19. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

    著者: Ellen Stelloo, Tjalling Bosse, Remi A. Nout, Helen Mackay, David N. Church, Hans W. Nijman, Alexandra Léary, Richard J. Edmondson, Melanie Powell, Emma J. Crosbie, Henry C Kitchener, Linda Mileshkin, Pamela M. Pollock, Vincent T.H.B.M. Smit, Carien L. Creutzberg - Modern Pathology 2015 被引用: 490

  20. Practical guidance for mismatch repair-deficiency testing in endometrial cancer

    著者: Ellen Stelloo, Anna M. Jansen, Elisabeth M. Osse, Remi A. Nout, Carien L. Creutzberg, Dina Ruano, David N. Church, Hans Morreau, Vincent T.H.B.M. Smit, Tom van Wezel, Tjalling Bosse - Annals of Oncology 2016 被引用: 346

  21. Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis

    著者: Jessica N. McAlpine, Derek S. Chiu, Remi A. Nout, David N. Church, Pascal Schmidt, Stéphanie Lam, Samuel Leung, Stefania Bellone, Adele Wong, Sara Y. Brucker, Cheng‐Han Lee, Blaise Clarke, David G. Huntsman, Marcus Q. Bernardini, Joanne Ngeow, Alessandro D. Santin, Paul J. Goodfellow, Douglas A. Levine, Martin Köbel, Stefan Kommoss, Tjalling Bosse, C. Blake Gilks, Aline Talhouk - Cancer 2021 被引用: 156

  22. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer

    著者: Nicoletta Colombo, Carien L. Creutzberg, Frédéric Amant, Tjalling Bosse, Antonio González-Martı́n, Jonathan A. Ledermann, Christian Marth, Remi A. Nout, Denis Querleu, Mansoor Raza Mirza, Cristiana Sessa - International Journal of Gynecological Cancer 2015 被引用: 757

  23. Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy

    著者: Anne Sophie V M van den Heerik, Nanda Horeweg, Stephanie M. de Boer, Tjalling Bosse, Carien L. Creutzberg - International Journal of Gynecological Cancer 2020 被引用: 199

  24. Incorporation of molecular characteristics into endometrial cancer management

    著者: Lisa Vermij, Vincent T.H.B.M. Smit, Remi A. Nout, Tjalling Bosse - Histopathology 2019 被引用: 299